Member Info for Soupdragon78

Fx, nuformix can’t change the ERS deadlines.

I think partly due to deadlines to submit to the ERS.

The main submission deadline for papers was in February, then the late submission deadline was end of May so still might have been to tight to fully write up and submit.

Late breaking submissions are now shown within the programme and the company would have been notified by mid July whether they had a place or not.

My feeling is that when Dan mentioned the ERS, he was meaning more about networking and talking to others rather than presenting or poster session.

Exciting! Pity NFX aren’t presenting at the ERS, likely only attending as a visitor.

You can search the Congress programme of companies presenting here.

https://k4.ersnet.org/prod/v2/front/program/?e=379

FX, you need to think about what you're writing. I don't mind critical commenting, but some comments just seem to lack basic thinking and logic. On one hand you say you want an outlicensing then immediately follow it saying that if its not happened by now then its not likely.

The AGM resolutions are there to provide potential avenues should they need them. Its not a binary item that they can only do an outlicensing deal or do a placing. The most likely occurrence is both will happen. Look at other companies such as RedX which outlicenced to AZ in Aug 2020 then formed a partnership with Jazz Pharma for $10m upfront in Sept 2020 and then raised £25m just 3 months later.

It would be business suicide to not have a mechanism to enable funding of some kind as they would then have to announce in the report that they would not have the money to continue as a business.

From my side, I just found it interesting that for the first time in Nuformix history they have included a resolution to allow a rights issue for existing shareholders. If you choose to see that as negative with everything else then thats your perogative.

Thanks for the constructive input Fx. Sounds like you want the company to wind up so you can blame them for your loss rather than make the decision yourself.

'They should be looking to raise funds through licensing deals not share issues'

Come on FX, are you seriously saying that the company should cut off all other avenues of funding on the off chance of someone signing a deal with them. I'm glad you're not signing off the accounts.

Indeed jiving, the buyback is a standard clause that they've had in previous agm years. The rights issue for existing shareholders is new to this years resolution, hence it got my interest.

What bit of it is a concern?

It means they will offer shares to existing shareholders as part of any placing.

AGM resolution 4 (b) is one i've not seen the company put out before. Its quite interesting for holders.

Why would you assume that?

Well if he was serious about exposing ‘ghost biotech’ for what they are then he’d buy one share and attend to address the issue directly.

But I doubt he’s got the guts.

It’ll be good to see Mulder at the agm so he can tell Dan directly about there being no hope.

I’ve just looked back through the last 150 posts here about nfx, the one that got the most recommendations had 5 votes for it, and that was me saying that Superdrug should buy NXP002 and put it next to the fungal foot cream.

Hardly a hotbed of influence is it!

The amount of people that read this lse thread on nfx is barely in double figures, if you were that concerned about ‘ghost biotechs’ and the influence I was having then you’d start up a telegram or Twitter feed which reaches a much wider audience.

Thing is Mulder, we don’t need to form an argument around anything because I’m not trying to push an agenda.

No reason for you to be posting then.

Turns out inflammation can mean quite a lot of things, sometimes it pays to be specific.

Robbo, my post was in regarding Mulder, nothing for you to apologise for.

It says a lot when all someone has got to say is that they are ‘richer’ than others.